Silvio E. Inzucchi, MD
Director, Yale Medicine Diabetes Center
Professor of Medicine, Endocrinology
Yale University School of Medicine
New Haven, CT
Anne L. Peters, MD
Professor of Medicine
Keck School of Medicine
University of Southern California
Westside Center for Diabetes
Los Angeles, CA
- Select therapies for the improvement of glycemic and extra-glycemic outcomes in patients with T2DM.
- Determine the rationale for targeting GIP and GLP-1 receptors in the treatment of type2 diabetes and its metabolic comorbidities.
- Identify patients in their own practice who may potentially benefit from treatments targeting GIP and GLP-1 receptors in the future based on knowledge of recent clinical data
This educational activity is intended for a global audience of endocrinologists, primary care physicians, NPs, PAs, nurses, and other clinicians involved in the treatment of patients with type 2 diabetes mellitus (T2DM).
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.5 AMA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with type 2 diabetes mellitus.
CNE Credits: 1.5 ANCC Contact Hours.
Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.5 contact hour(s) of continuing nursing education of RNs and APNs.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.5 contact hours of continuing nursing education of RNs and APNs.
COMMISSION ON DIETETIC REGISTRATION
This program has received prior approval with the Commission on Dietetic Registration for Dietitians and Registered Dieticians.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF FINANCIAL RELATIONSHIP
Dr. Inzucchi discloses that he is consultant for Boehringer Ingelheim, AstraZeneca, Sanofi/Lexicon, Novo Nordisk, Merck, vTv Therapeutics, Zafgen, Abbott/Alere, Eisai (TIMI). He has also received royalties from McGraw-Hill and Uptodate and has received salary from Elsevier.
Dr. Peters discloses that she is on the speakers’ bureau for Novo Nordisk. She is a consultant for Abbott Diabetes Care, Becton Dickinson, Boehringer Ingelheim, Eli Lilly and Company, Lexicon, Livongo, MannKind, Medscape, Merck, Novo Nordisk, Omada Health, OptumHealth, Sanofi, and Zafgen. Dr. Peters has also received research support from AstraZeneca, Dexcom, and MannKind and donated devices from Abbott Diabetes Care.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner
The reviewer of this activity has nothing to disclose
Staff Planners and Managers
The independent reviewers, staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests:
Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Russie Allen, Outcomes Coordinator for Med Learning Group has nothing to disclose.
Diana Tommasi, PhD, Medical Director, Scientific and Medical Services for Med Learning Group has nothing to disclose.
Melissa A. Johnson, Senior Program Manager for Med Learning Group has nothing to disclose.
Amanda Jenkins, Associate Program Manager for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME/CNE credit for this web-based enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the web-based enduring activity.
- Complete and submit the evaluation form to Med Learning Group.
You will receive your certificate after the enduring activity.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at email@example.com
For CME questions, please contact Med Learning Group at firstname.lastname@example.org.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://medlearninggroup.com/privacy-policy/
RELEASE DATE: December 28, 2021
EXPIRATION DATE: December 28, 2022
Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.